📰 Exact Sciences News
Page 3 - Exact Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exact Sciences. Real-time updates on events, politics, business and more.
May 20, 2024
Inflation falls, bonds and equities rise and meme stocks make a comeback
May 18, 2024
The annual tally of patents with at least one Rochester inventor is now dropping as IBM is filing for fewer patents. However, patents by Mayo Clinic and Oshkosh inventors are on the rise.
May 17, 2024
The organization will show off its new office space Wednesday in the Black Business Hub on South Park Street.
May 6, 2024
According to FactSet, a financial data analytics firm, 80% of S&P 500 companies have reported earnings so far.
May 4, 2024
Without any major economic reports, earnings — especially forward guidance and management commentary — will drive the action.
May 1, 2024
Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to...
April 30, 2024
This modeling study uses Cancer Intervention and Surveillance Modeling Network models and national data on breast cancer incidence, mammography
April 27, 2024
Abrdn plc grew its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 48.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 106,106 shares of the medical research company’s stock after purchasing an additional 34,494 shares during the period. abrdn plc […]
April 27, 2024
Motley Fool Asset Management LLC lessened its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,931 shares of the medical research company’s stock after selling 310 shares during the quarter. Motley […]
April 27, 2024
Motley Fool Asset Management LLC cut its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,931 shares of the medical research company’s stock after selling 310 shares during the quarter. […]